Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹464Cr
Rev Gr TTM
Revenue Growth TTM
17.18%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ALUFLUOR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 22.4 | 36.1 | 24.5 | -1.0 | 29.4 | -8.0 | 19.2 | 26.5 | 18.2 | 29.8 | 3.1 | 23.1 |
| 28 | 29 | 34 | 30 | 37 | 26 | 43 | 37 | 49 | 37 | 41 | 45 |
Operating Profit Operating ProfitCr |
| 20.1 | 20.4 | 22.8 | 19.7 | 18.5 | 22.4 | 19.9 | 22.8 | 9.0 | 16.4 | 25.4 | 23.9 |
Other Income Other IncomeCr | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 5 | 5 | 8 | 5 | 6 | 5 | 8 | 8 | 3 | 4 | 11 | 12 |
| 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 3 | 3 |
|
Growth YoY PAT Growth YoY% | 425.0 | 108.4 | 81.9 | -24.6 | 67.9 | 17.0 | 22.2 | 69.9 | -71.6 | -18.0 | 19.3 | 55.9 |
| 8.9 | 8.8 | 12.2 | 9.5 | 11.6 | 11.2 | 12.5 | 12.7 | 2.8 | 7.1 | 14.5 | 16.1 |
| 4.5 | 4.3 | 7.2 | 4.3 | 6.8 | 4.9 | 8.5 | 7.7 | 1.9 | 4.0 | 10.1 | 26.2 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 128.5 | 54.8 | 21.0 | 14.4 | 12.0 |
| 37 | 75 | 111 | 131 | 155 | 171 |
Operating Profit Operating ProfitCr |
| 4.1 | 15.2 | 18.6 | 20.4 | 17.8 | 18.9 |
Other Income Other IncomeCr | 1 | 1 | 3 | 2 | 2 | 2 |
Interest Expense Interest ExpenseCr | 1 | 3 | 3 | 3 | 2 | 3 |
Depreciation DepreciationCr | 3 | 6 | 7 | 9 | 9 | 9 |
| -1 | 5 | 18 | 24 | 24 | 31 |
| -1 | 1 | 5 | 6 | 6 | 9 |
|
| | 740.5 | 254.4 | 40.3 | 3.3 | 21.4 |
| -1.4 | 4.0 | 9.2 | 10.6 | 9.6 | 10.4 |
| -0.7 | 4.9 | 16.4 | 22.6 | 23.1 | 42.2 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 8 | 8 | 8 | 8 | 8 | 8 |
| 44 | 48 | 60 | 77 | 94 | 104 |
Current Liabilities Current LiabilitiesCr | 13 | 18 | 19 | 22 | 15 | 14 |
Non Current Liabilities Non Current LiabilitiesCr | 30 | 27 | 27 | 21 | 31 | 38 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 26 | 33 | 45 | 59 | 76 | 83 |
Non Current Assets Non Current AssetsCr | 70 | 67 | 69 | 70 | 72 | 81 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -2 | 4 | 21 | 35 | 12 |
Investing Cash Flow Investing Cash FlowCr | -11 | -6 | -18 | -19 | -19 |
Financing Cash Flow Financing Cash FlowCr | 16 | -5 | -2 | -11 | 1 |
|
Free Cash Flow Free Cash FlowCr | -9 | -33 | 6 | 27 | 1 |
| 406.6 | 103.9 | 168.1 | 199.7 | 66.8 |
CFO To EBITDA CFO To EBITDA% | -141.4 | 27.4 | 82.7 | 104.0 | 36.0 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 174 | 236 | 234 | 365 | 362 |
Price To Earnings Price To Earnings | 0.0 | 67.0 | 18.3 | 20.6 | 20.0 |
Price To Sales Price To Sales | 4.5 | 2.7 | 1.7 | 2.2 | 1.9 |
Price To Book Price To Book | 3.4 | 4.2 | 3.5 | 4.3 | 3.6 |
| 124.7 | 19.8 | 10.4 | 11.3 | 11.5 |
Profitability Ratios Profitability Ratios |
| 33.6 | 33.6 | 35.0 | 36.0 | 34.1 |
| 4.1 | 15.2 | 18.6 | 20.4 | 17.8 |
| -1.4 | 4.0 | 9.2 | 10.6 | 9.6 |
| -0.2 | 8.9 | 20.9 | 24.7 | 20.2 |
| -1.1 | 6.3 | 18.4 | 20.7 | 17.8 |
| -0.6 | 3.5 | 10.9 | 13.7 | 12.2 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Alufluoride Limited is a specialized Indian chemical manufacturer and the leading producer of high-purity **Aluminium Fluoride (AlF3)** in Andhra Pradesh. The company operates within the **Inorganic Chemicals** segment, providing a critical additive for the primary aluminium industry. By utilizing specialized technology to convert fluorine effluents from phosphatic fertilizer complexes into high-value chemicals, Alufluoride occupies a unique niche in the circular economy, reducing the environmental footprint of aluminium smelting while maintaining a dominant domestic market position.
---
### **Core Product Portfolio and Revenue Streams**
The company’s business model is centered on the electrolysis process of aluminium production.
* **Primary Product (AlF3):** A critical flux used in aluminium smelters to lower the melting point of alumina, thereby reducing energy consumption and carbon emissions during production.
* **Revenue Recognition:** Income is recognized at the **transaction price** (net of discounts and schemes) upon the transfer of control to the customer.
* **Ancillary Income:** The company supplements core operations through:
* **Interest Income** via the effective interest method.
* **Dividend Income** and **Gains/Losses on Investments**.
* **Waste Monetization:** While **Silica** is a process waste usually disposed of as an expense, irregular quantities are occasionally sold to generate minor revenue.
| Revenue Component | Accounting Treatment |
| :--- | :--- |
| **Core Product** | Inclusive of **excise and duties**; exclusive of **GST** |
| **Deductions** | Net of **returns, trade allowances, and rebates** |
| **Foreign Operations** | Assets/liabilities subject to **fair value adjustments** and **closing rate translation** |
---
### **Manufacturing Infrastructure and Sustainable Operations**
Alufluoride operates a sophisticated manufacturing base in Visakhapatnam, characterized by increasing scale and a commitment to green energy.
* **Production Capacity:** Following a brownfield expansion in **May 2021**, capacity reached **15,000 MTPA**. Ongoing enhancements are targeting a capacity of **18,000 MTPA**.
* **Energy Sustainability:** To mitigate rising power costs, the company operates **3 MW Solar Power Generation Panels** at Polepalli, Anakapalli. This includes a **1.1 MW Solar Plant** specifically financed to support sustainable operations.
* **Client Base:** The company supplies all major aluminium smelters in India and maintains relationships with select international smelters.
---
### **Supply Chain Dynamics and Raw Material Security**
The company’s production relies on **Hydrofluosilicic Acid (FSA)** and **Silicic Acid**, sourced through strategic long-term partnerships with fertilizer majors.
* **Primary Source:** An agreement with **Coromandel International Limited (CIL)** for **3,500 TPA** of acid.
* **Supplementary Sources:** To support expanded capacity, the company has secured:
* **IFFCO, Paradeep:** Long-term contract for a minimum of **7,000 TPA** (with actual supply potential up to **19,000 TPA**).
* **Paradeep Phosphates Ltd:** Contract for **2,500 to 5,000 TPA**.
* **Logistical Challenges:** Inconsistency in supply from the adjacent CIL complex often necessitates procurement from distant sources in Odisha. This increases vulnerability to **escalating fuel prices** and higher transportation costs.
---
### **Strategic Pivot: Domestic Focus and Backward Integration**
In **2025**, Alufluoride underwent a significant strategic transformation, shifting away from international expansion to focus on domestic resilience and supply chain integration.
* **Withdrawal from Jordan:** Due to geopolitical instability in the Middle East and financing constraints, the company disinvested from its **25,000 TPA** greenfield project (**JRAFMC**) in Jordan. The disinvestment was finalized on **May 9, 2025**.
* **Alumina Hydrate Project:** To combat a **70% surge** in raw material prices, the company is exploring a new facility to manufacture **Alumina Hydrate**. Shareholders approved an amendment to the **Objects Clause** in **April 2025** to facilitate this backward integration.
* **Corporate Restructuring:** The company de-registered its UAE subsidiary in **2022** and is managing its remaining international interests through **Alufluoride International Pte. Ltd. (Singapore)**.
---
### **Financial Performance and Capital Structure**
The company achieved record production and sales in **FY 2024-25**, supported by a conservative debt profile and efficient working capital management.
**Growth Trajectory:**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Production (MT)** | **16,377** | **15,016** | **13,801** |
| **Sales (MT)** | **15,831** | **15,260** | **13,662** |
| **Revenue (₹ Crore)** | **190.53** | **166.68** | **138.91** |
| **Net Profit (₹ Crore)** | *Record High* | **18.54** | **14.15** |
**Solvency and Liquidity:**
As of **March 31, 2025**, the **Debt to Equity ratio** stood at a healthy **0.22**.
* **Total Equity:** **₹102.89 Crore** (up from **₹69.34 Crore** in 2023).
* **Banking Transition:** Moved to **Punjab National Bank (PNB)** for competitive rates; PNB sanctioned **₹23.5 Crore** in term loans and increased working capital limits to **₹15 Crore**.
* **Taxation:** Opted for the new corporate tax rate (**Section 115BAA**), resulting in an effective rate of **25.168%**.
* **Shareholder Returns:** Maintained a consistent dividend track record, recommending **₹3.00 (30%)** per share for **FY 2024-25**.
---
### **Risk Management and Mitigation Framework**
Alufluoride employs a structured approach to navigate operational and financial volatility.
* **Geopolitical & Market Risk:** The withdrawal from Jordan has eliminated Middle Eastern exposure, though it resulted in a **₹2.61 crore** provision for diminution in the value of the Singapore subsidiary. The company currently reports **zero registered export sales**.
* **Interest Rate Sensitivity:** A **0.5%** change in interest rates impacts profit by approximately **₹11.65 Lakhs**.
* **Equity Price Risk:** The company manages a diversified investment portfolio; a **5%** shift in equity prices impacts profit by **₹1.07 Crore**.
* **Credit Risk:** Managed via a strict policy with an average collection period of **<30 days**.
* *Provisioning:* **0%** for debts <3 months; **100%** for debts >3 years.
* **Regulatory Compliance:** The company has accounted for a **₹21.22 Lakh** liability following the **2019 Code on Wages** and subsequent labor code notifications in **November 2025**.
---
### **Leadership and Governance**
Effective **March 10, 2025**, **Sri Aditya Akkineni** was appointed as **Whole-Time Director and CEO** to spearhead the company’s new phase of domestic expansion and diversification into fluorine derivatives. As of **December 31, 2025**, the company reported **nil** pending investor complaints and **no major pending litigations** that could materially impact its financial standing.